Anish Suri
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anish Suri
The proxy statement of Cue Biopharma, Inc. reports total compensation of $1,180,114 for Anish Suri in fiscal 2024, including a base salary of $465,411. Disclosed compensation is on record for 7 fiscal years. Anish Suri has spoken on 1 earnings call across 1 company, most recently for Cue Biopharma, Inc. on September 30, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cue Biopharma, Inc. (CUE)
Proxy statement
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cue Biopharma, Inc. (CUE) | Former President and Chief Scientific Officer | $465,411 | $1,180,114 |
| 2023 | Cue Biopharma, Inc. (CUE) | Former President and Chief Scientific Officer | $481,486 | $1,242,468 |
| 2022 | Cue Biopharma, Inc. (CUE) | President and Chief Scientific Officer | $489,832 | $1,167,653 |
| 2021 | Cue Biopharma, Inc. (CUE) | President and Chief Scientific Officer | $436,542 | $1,521,227 |
| 2020 | Cue Biopharma, Inc. (CUE) | President and Chief Scientific Officer | $420,000 | $2,128,670 |
| 2019 | Cue Biopharma, Inc. (CUE) | President and Chief Scientific Officer | $366,250 | $4,559,814 |
| 2018 | Cue Biopharma, Inc. (CUE) | President and Chief Scientific Officer | $207,863 | $3,221,156 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.